Creative Medical Technology Holdings, Inc. Payments to Fund Long-term Loans to Related Parties
Creative Medical Technology Holdings, Inc. (CELZ) reported Payments to Fund Long-term Loans to Related Parties of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:PaymentsToFundLongtermLoansToRelatedParties · last filed 2022-11-10
- 2022-09-30: Payments to Fund Long-term Loans to Related Parties 9 month $0.00.
- 2021-09-30: Payments to Fund Long-term Loans to Related Parties 9 month $200.00K.
| Period end | Payments to Fund Long-term Loans to Related Parties 9 month |
|---|---|
| 2022-09-30 | $0.00 10-Q · filed 2022-11-10 |
| 2021-09-30 | $200.00K 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |